November 3, 2022

Developing and Validating Clinical Receptor Occupancy Pharmacodynamic Biomarker Assays

May 27, 2021

Experience With Multiple Myeloma Rescues a Global Phase 3 Trial

May 27, 2021

Harnessing Flow Cytometry Data to Keep a Phase 1 Trial on Track

May 27, 2021

When the FDA Has Questions: Finding Answers in the Data

October 6, 2022
Antibody proteins attack a corona virus pathogen cell - 3d illustration

Noninvasive Immunophenotyping Using Epiontis ID™: Evaluating COVID-19 Disease Course and Measuring SARS-CoV-2 Vaccine Response

October 6, 2022
Epigenetic Immunophenotyping for treatment of Hepatocellular Carcinoma

Exploring Biomarkers to Predict the Response to Immunotherapy-Based Combination Treatment in Hepatocellular Carcinoma Using Epiontis ID™

May 27, 2021

A “Basket” Trial and an Accelerated Pathway to Proof-of-Concept

May 27, 2021

Securing Enrollment for a Complex Phase 2 Trial in Eosinophilic Esophagitis Ahead of Schedule

May 27, 2021

Development of an IHC-Based Assay for Detection Of P-Cadherin in Tumor Tissue

Development of an IHC-Based Assay for Detection Of P-Cadherin in Tumor Tissue Clinical Application: Patient Selection for Enrollment Key Words: patient stratification, tumor biopsies, quantitative IHC Background: Personalized medicine is an emerging idea in health care; the ability to determine a patient’s responsiveness to a given treatment in advance, through […]